GlassScriptPhysician profile
Jason C Park
NPI 1457554826
$2,287.81
in general payments reported to CMS, 2019-2025
20 companies · $454 in 2025
The $454 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,001 · 2020: $116 · 2021: $226 · 2022: $74.01 · 2023: $71.89 · 2024: $346 · 2025: $454.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $872.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $871.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,416.39 | 2019-2025 | Alphavent, Mako, Triathlon |
| Pacira Therapeutics, INC. | $229.94 | 2019-2021 | |
| Abbvie INC. | $167.00 | 2021-2024 | |
| Heron Therapeutics, INC. | $102.75 | 2022-2025 | Zynrelef |
| Boston Scientific Corporation | $47.16 | 2025 | Wavewriter Alpha Prime 16 |
| Linvatec Corporation | $40.30 | 2023-2024 | Biobrace 23mm, Allograft Tissue |
| Fx Shoulder Solutions, INC | $31.76 | 2019 | |
| Horizon Therapeutics Plc | $31.36 | 2022 | |
| Sanofi-Aventis U.S. LLC | $29.78 | 2019-2020 | |
| Paratek Pharmaceuticals, INC. | $26.62 | 2025 | Nuzyra |
| Djo, LLC | $24.14 | 2025 | Cmf |
| Tactile Systems Technology INC | $19.72 | 2023 | Flexitouch Plus, Entre Plus |
| Olympus America INC. | $18.56 | 2025 | Tecoflex, Olympus, Olympus |
| Smith+Nephew, INC. | $17.94 | 2019 | |
| Kinex Medical Company LLC | $16.84 | 2020 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $16.57 | 2024 | Ligasure |
| Bioventus LLC | $15.89 | 2021 | |
| Biocomposites INC | $14.36 | 2023 | Stimulan |
| Baudax Bio INC. | $11.40 | 2021 | |
| Medela LLC | $9.33 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Park listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.